Jie Li

The mTOR signaling pathway is an emerging therapeutic target in multiple myeloma.

X. Mao, B. Cao, Jie Li, 2014, Current pharmaceutical design.

, 3-kinase pathway preclinical efficacy in myeloma and leukemia via phosphoinositide A small-molecule inhibitor of D-cyclin transactivation displays

M. Moran, A. Datti, Jiefei Tong, 2011 .

Cyproheptadine‐induced myeloma cell apoptosis is associated with inhibition of the PI3K/AKT signaling

X. Mao, B. Cao, Jie Li, 2013, European journal of haematology.

Deoxynivalenol induces caspase-3/GSDME-dependent pyroptosis and inflammation in mouse liver and HepaRG cells

Jie Li, Jun Jiang, Yiqun Deng, 2022, Archives of Toxicology.

The Antiparasitic Clioquinol Induces Apoptosis in Leukemia and Myeloma Cells by Inhibiting Histone Deacetylase Activity*

Yang Yu, Tingjun Hou, Jingyu Zhu, 2013, The Journal of Biological Chemistry.

Dissecting bortezomib: development, application, adverse effects and future direction.

X. Mao, B. Cao, Jie Li, 2013, Current pharmaceutical design.